During the past decade, Universitat Munchen / Medizinische Poliklinik conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitat Munchen / Medizinische Poliklinik" #1 collaborator was "Glaxo Wellcome" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitat Munchen / Medizinische Poliklinik" are "HIV Infections" (2 trials), "Candidiasis, Oral" (1 trials) and "Pneumonia, Pneumocystis Carinii" (1 trials). Many other conditions were trialed in "Universitat Munchen / Medizinische Poliklinik" in a lesser frequency.

Most popular intervention types in "Universitat Munchen / Medizinische Poliklinik" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atovaquone" (1 trials), "Fluconazole" (1 trials), "Posaconazole" (1 trials) and "Sulfamethoxazole-Trimethoprim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitat Munchen / Medizinische Poliklinik" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitat Munchen / Medizinische Poliklinik". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitat Munchen / Medizinische Poliklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitat Munchen / Medizinische Poliklinik, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".